Discontinuation of Intravenous Catecholamine by Oral Ivabradine in a Patient with Decompensated Heart Failure with Low Cardiac Output Syndrome

Kurume Med J. 2023 Jul 3;68(2):133-140. doi: 10.2739/kurumemedj.MS682007. Epub 2023 Apr 17.

Abstract

Ivabradine has been shown to improve heart failure with sinus tachycardia by reducing the heart rate without affecting left ventricular systolic function or blood pressure. Here we report a case of a catecholaminedependent patient, New York Heart Association (NYHA) class IV, LVEF of 18%, and low cardiac output, who was able to discontinue intravenous catecholamine by oral administration of ivabradine.

Keywords: ivabradine; low cardiac output; severe heart failure.

Publication types

  • Case Reports

MeSH terms

  • Cardiac Output, Low* / drug therapy
  • Catecholamines
  • Heart Failure* / complications
  • Heart Failure* / drug therapy
  • Heart Rate / physiology
  • Humans
  • Ivabradine

Substances

  • Ivabradine
  • Catecholamines